Complement components as uremic toxins and their potential role as mediators of microinflammation

Kidney International, Supplement

Volumn 59, Issue 78, 2001, Pages S271-S277

  Deppisch, Reinhold M ^a,b   Beck, Werner ^a,b   Goehl, Hermann ^a,b   Ritz, Eberhard ^a,b  

^a Gambro Research   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Atherosclerosis; Biocompatibility; Factor D; Hemodialysis; Inflammation; Vascular damage

Indexed keywords

AUTACOID; C REACTIVE PROTEIN; COMPLEMENT; TOXIN; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR D; ENDOTOXIN;

ACUTE PHASE RESPONSE; ARTERIOSCLEROSIS; BIOLOGICAL MODEL; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; COMPLEMENT ACTIVATION; ENDOTOXEMIA; HUMAN; IMMUNOLOGY; INFECTION; METABOLISM; RENAL REPLACEMENT THERAPY; REVIEW; UREMIA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOCOMPATIBILITY; COMPLEMENT SYSTEM; CONFERENCE PAPER; DIALYSIS; DISEASE COURSE; HEMODIALYSIS; INFLAMMATION; KIDNEY DISEASE; NONHUMAN; PRIORITY JOURNAL;

ACUTE-PHASE REACTION; ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; ENDOTOXEMIA; HUMANS; INFECTION; INFLAMMATION MEDIATORS; KIDNEY FAILURE, CHRONIC; MODELS, BIOLOGICAL; RENAL REPLACEMENT THERAPY; TOXINS, BIOLOGICAL; UREMIA;

EID: 0035122308     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.59780271.x     Document Type: Article

References (53)

1. Excerpts from United States Renal Data System 1999 Annual Data Report
2. Deaths within 90 days from starting renal replacement therapy in the ERA-EDTA Registry between 1990 and 1992
3. Atherosclerosis: An inflammatory disease
4. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
5. Serum C-reactive protein (CRP) and risk of death in chronic dialysis
6. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina
7. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men
8. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
9. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
10. Malnutrition, cardiac disease, and mortality: An integrated point of view
11. Interaction with effector cells
12. Is complement a target for therapy in renal disease?
13. Complement activation of artificial surfaces in biomedical therapies
14. Analysis of complement C3 activation products in human atherosclerotic lesions
15. Alternative pathway: Activation and regulation
16. Lectin pathway of non-self recognition
17. Fluid phase generation of terminal complement complex as a novel index of bioincompatibility
18. Elevated plasma levels of the immunosuppressive complement: Fragment Ba in renal failure
19. Acute-phase proteins and other systemic responses to inflammation
20. Bioincompatibility: Perspectives in 1993
21. Microdomain structure of polymeric surfaces: Potential for improving blood treatment procedures
22. Gene expression of interleukin-1β during hemodialysis
23. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation
24. Studies of biocompatibility of different dialyzer membranes: Role of complement system, intracellular calcium and inositol-triphosphate
25. Metabolism of complement factor D in renal failure
26. Inhibition of degranulation of human polymorphonuclear leukocytes by complement factor D
27. Significant reduction of factor D and immunosuppressive complement fragment Ba by hemofiltration
28. Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and a high-flux biocompatible membrane
29. Increased expression of the CD11b/CD18 antigen on the surface of peripheral white blood cells in patients with ischemic heart disease: Further evidence for smoldering inflammation in patients with atherosclerosis
30. Role of proteinase/antiproteinase disequilibrium in the bioincompatibility induced by artificial surfaces
31. Permeability of dialyzer membranes to TNFα-inducing substances derived from water bacteria
32. The immune system in end-stage renal disease
33. Isolation of a granulocyte inhibitory protein from uraemic patients with homology of β2-microglobulin
34. Genesis of the uraemic syndrome: Role of uraemic toxins
35. Binding of human C-reactive protein to bacteria
36. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis
37. C-reactive protein: A physiological activator of interleukin 6 receptor shedding
38. Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlated with markers of endothelial dysfunction: Evidence for chronic inflammation
39. Cu-prammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complement
40. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients
41. Transcriptional regulation of complement genes
42. Quantitative determination of complement components produced by purified hepatocytes
43. Complement activation by C-reactive protein complexes
44. C3 deposition in cholesterol-induced atherosclerosis in rabbits: A possible etiologic role for complement in atherogenesis
45. Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque
46. Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions
47. Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells
48. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries
49. Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria 1
50. Complement-endothelial cell interactions: Pathophysiological implications
51. Molecular basis for a link between complement and the vascular complications of diabetes